Since the Firm’s founding, Longwood Fund, and its principals, have been active in co-founding leading biotechs serving in company leadership roles as well as lead investor, and anticipates being ...

LEVERKUSEN, Germany and BOSTON, July 17, 2019 /PRNewswire/ -- Pyxis Oncology ("Pyxis"), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody ...

Longwood Fund to narrow its focus with new $180M fund. expand. Courtesy photos. By Rowan Walrath – Life Sciences Reporter, Boston Business Journal. May 4, 2023. Preview this article 1 min.

Logo BOSTON - September 8, 2022 - (Newswire.com) Longwood Fund, an early-stage life science venture firm focused on company creation, will convene several hundred top biotech and pharmaceutical ...

In February 2010, the Fund made its first investment in Alnara Pharmaceuticals, Inc., a company co-founded by members of the Longwood team and Dr. Alexey Margolin.Alnara’s lead drug, liprotamase ...